Fentanyl addiction treatment helps people address opioid use that has become difficult to control and increasingly dangerous. Fentanyl is a powerful synthetic opioid that can cause physical dependence, opioid use disorder, respiratory depression, and fatal overdose. A person may use pharmaceutical fentanyl as prescribed, intentionally seek illegally manufactured fentanyl, or consume the substance unknowingly in heroin, cocaine, methamphetamine, or counterfeit pills. At Rainbow Hill Recovery, we provide LGBTQIA+-affirming outpatient fentanyl addiction treatment in Los Angeles for adults who are medically stable and able to participate safely in ongoing behavioral care.
Our approach recognizes that fentanyl use does not occur separately from a person’s emotional health, identity, trauma history, relationships, and daily environment. LGBTQIA+ adults may enter treatment after experiencing rejection, discrimination, identity concealment, family conflict, harassment, or healthcare settings where they did not feel respected. Sexual orientation and gender identity do not cause addiction, but identity-related stress may influence mental health, social connection, treatment trust, and the ways someone attempts to cope with distress. Affirming care allows clients to discuss these experiences without being stereotyped, misgendered, or asked to minimize an important part of who they are.
Fentanyl is a laboratory-made opioid that is similar to morphine but considerably more potent. Pharmaceutical fentanyl has accepted medical uses, including managing severe pain after surgery or during treatment for advanced cancer. Illegally manufactured fentanyl is produced and distributed outside regulated medical systems, making its dosage, strength, and ingredients unpredictable. The National Institute on Drug Abuse describes fentanyl as approximately 50 to 100 times more potent than morphine, meaning a relatively small amount can suppress breathing and cause a fatal overdose.
Illegally manufactured fentanyl may be sold as a powder, mixed into other drugs, or pressed into counterfeit tablets. These pills may resemble oxycodone, hydrocodone, alprazolam, or other familiar medications even though they were not produced by a licensed pharmaceutical manufacturer. A person cannot reliably determine whether fentanyl is present by looking at, smelling, tasting, or touching a pill or powder. This uncertainty is one reason fentanyl has become a leading contributor to fatal and nonfatal drug overdoses across the United States.
Fentanyl addiction is generally diagnosed as an opioid use disorder when continued opioid use causes significant impairment, distress, or harm. The condition may involve cravings, impaired control, tolerance, withdrawal, risky behavior, neglected responsibilities, and continued use despite serious consequences. Opioid use disorder can range from mild to severe depending on the number of recognized symptoms that occur within a 12-month period. Someone does not need to experience homelessness, job loss, arrest, or a near-fatal overdose before treatment becomes appropriate.
Physical dependence and addiction are related, but they are not identical. Physical dependence means the body has adapted to repeated opioid exposure and may produce withdrawal symptoms when use is reduced or stopped. Addiction involves a broader behavioral pattern that may include compulsive use, cravings, impaired decision-making, and continued use despite harm. A person may experience dependence, opioid use disorder, or both, making an individualized medical and behavioral assessment important.
There is no single cause of fentanyl addiction, and opioid use disorder is not evidence of weak character or insufficient willpower. Risk may be affected by genetics, family history, trauma, chronic pain, repeated opioid exposure, mental health symptoms, social isolation, unstable housing, and access to drugs. Some people first encounter fentanyl through medically prescribed pain treatment, while others are exposed through heroin, counterfeit tablets, or another substance. Treatment must therefore consider how opioid use began as well as the biological, emotional, and environmental factors that continue to reinforce it.
Depression, anxiety, grief, trauma, loneliness, and overwhelming stress may become closely connected to fentanyl use. Opioids can temporarily reduce physical and emotional pain, but their effects do not resolve the conditions creating that distress. As tolerance and physical dependence develop, a person may begin using primarily to prevent withdrawal rather than to experience pleasure. Effective treatment addresses opioid use while helping clients manage emotional symptoms, relationships, pain concerns, and daily pressures in safer ways.
Environmental conditions may further strengthen the cycle. Living with people who use opioids, experiencing housing instability, lacking reliable healthcare, or having regular access to counterfeit pills can make change more difficult. Financial pressure, relationship conflict, unemployment, and repeated exposure to overdose may increase anxiety and create additional triggers. A comprehensive treatment plan helps clients identify these pressures and build practical strategies that support stability outside scheduled therapy sessions.
Fentanyl addiction may develop quickly because of the drug’s potency and ability to create strong physical dependence. Someone may continue meeting selected responsibilities while privately experiencing cravings, withdrawal, financial strain, or repeated unsuccessful efforts to stop. Partners, friends, relatives, or coworkers may notice changes in alertness, mood, reliability, appearance, or daily routines. A professional assessment is necessary because no single physical sign or behavior proves that someone has opioid use disorder.
Common warning signs may include:
Physical signs may include very small pupils, unusual drowsiness, slowed speech, impaired coordination, itching, nausea, constipation, or repeated periods of nodding off. Behavioral signs may include secrecy, unexplained absences, changing social groups, declining personal care, or missing money and belongings. A person may also become intensely anxious when fentanyl is unavailable because withdrawal symptoms can develop after regular use. The pattern becomes especially concerning when opioid use continues despite clear threats to breathing, judgment, safety, relationships, or daily functioning.
The 2024 National Survey on Drug Use and Health estimated that approximately 816,000 people aged 12 or older misused prescription fentanyl or used illegally manufactured fentanyl during the previous year. That total included about 668,000 people who reported using illegally made fentanyl. Federal health officials caution that survey figures may underestimate actual exposure because fentanyl can be present in heroin, cocaine, methamphetamine, or counterfeit pills without the person’s knowledge. Reported fentanyl use therefore does not capture every person who was unintentionally exposed to the drug.
Final federal mortality data recorded 47,735 overdose deaths involving synthetic opioids other than methadone in 2024, a category that primarily includes illegally manufactured fentanyl. The number was substantially lower than the 72,776 deaths recorded in 2023, while the age-adjusted death rate declined by 35.6%. This decrease represents important progress, but it does not make fentanyl use safe or eliminate the need for early treatment and overdose prevention. Synthetic opioids still accounted for most opioid-involved overdose deaths recorded during 2024.
LGBTQIA+ people may experience chronic stress connected to discrimination, family rejection, identity concealment, harassment, relationship violence, housing insecurity, or difficulty finding respectful healthcare. These experiences do not define every LGBTQIA+ client, and treatment should never assume that sexual orientation or gender identity is responsible for substance use. They may, however, influence anxiety, depression, trauma responses, isolation, and a person’s willingness to seek or remain engaged in care. LGBTQIA+-affirming treatment provides room to discuss these concerns when they are relevant while respecting the client’s name, pronouns, identity, privacy, culture, and boundaries.
Previous negative experiences in medical or behavioral health settings can become significant barriers to fentanyl treatment. A client may worry about being misgendered, having a partner excluded, encountering judgment about sexuality, or having legitimate pain and mental health concerns dismissed. These fears may delay treatment or make someone less willing to disclose substance use, withdrawal symptoms, or overdose history. At Rainbow Hill Recovery, affirming care means creating an environment where clients can discuss fentanyl use honestly without being asked to hide, defend, or explain who they are.
Fentanyl affects areas of the brain involved in pain, reward, alertness, and breathing. Short-term effects may include relaxation, euphoria, drowsiness, nausea, confusion, constipation, and slowed respiration. When breathing becomes too slow, the brain and other organs may be deprived of oxygen, potentially causing permanent injury or death. Combining fentanyl with alcohol, benzodiazepines, sleep medications, or other sedating substances can increase respiratory and overdose risks.
Ongoing fentanyl use can also affect sleep, nutrition, memory, motivation, relationships, and emotional stability. Depression and anxiety may intensify as the person becomes increasingly focused on obtaining opioids, avoiding withdrawal, and managing the consequences of use. Injecting fentanyl can cause vein damage and increase the risk of abscesses, HIV, hepatitis, bacterial infections, and infections involving the heart or other organs. Smoking or snorting fentanyl avoids needle-related risks but does not prevent addiction, respiratory depression, contamination, or overdose.
Some fentanyl supplies may also contain xylazine, a non-opioid sedative that is not approved for human use. Xylazine can slow breathing, heart rate, and blood pressure, and repeated exposure has been associated with serious wounds. Naloxone does not reverse xylazine itself, but it should still be administered during a suspected overdose because fentanyl or another opioid may also be involved. Emergency medical assistance remains necessary even when someone begins responding after naloxone.
Tolerance develops when repeated opioid exposure causes the same dose to produce a weaker or shorter effect. A person may begin using larger amounts, using more frequently, or combining fentanyl with other substances in an attempt to achieve the previous response. These changes raise the likelihood of respiratory depression, loss of consciousness, injury, infection, and overdose. Illicit fentanyl creates additional uncertainty because potency may differ significantly between pills, bags, batches, and individual portions.
Tolerance can decline after detoxification, hospitalization, incarceration, treatment, or another period without regular opioid use. Returning to an amount previously used may then cause an overdose because the body can no longer tolerate that dose. This makes a lapse after a period of abstinence a serious medical safety concern rather than only a setback in treatment. Relapse-prevention planning should include naloxone access, overdose education, and a clear plan for seeking immediate support.
Fentanyl withdrawal may cause anxiety, agitation, sweating, watery eyes, yawning, a runny nose, muscle aches, abdominal cramps, nausea, vomiting, diarrhea, insomnia, and intense cravings. The timing and intensity of symptoms can depend on the amount used, frequency, duration, route of administration, other substances, and the person’s physical health. Withdrawal is often extremely uncomfortable and may cause someone to resume fentanyl use simply to stop the symptoms. A return to use after tolerance has declined can create an especially high overdose risk.
Rainbow Hill Recovery provides outpatient behavioral health and substance use treatment rather than acute withdrawal management. Someone experiencing significant withdrawal, dehydration, pregnancy-related concerns, serious medical symptoms, or psychiatric instability should receive an appropriate medical evaluation before beginning routine outpatient programming. Once medically stable, the person may be assessed for our Partial Hospitalization Program, Intensive Outpatient Program, Outpatient Program, or Virtual IOP. Matching the level of care to the client’s current safety and stability helps support meaningful participation in treatment.
Methadone, buprenorphine, and naltrexone are FDA-approved medications for opioid use disorder. Methadone and buprenorphine can reduce withdrawal symptoms and cravings, while naltrexone blocks opioid effects after the required opioid-free period. These medications are not simply substitutes for uncontrolled fentanyl use when they are used within an appropriate clinical plan. They can help stabilize brain function, support treatment participation, reduce illicit opioid use, and lower overdose risk.
Each medication has different initiation requirements, benefits, and limitations. Methadone for opioid use disorder is dispensed through certified opioid treatment programs, while buprenorphine may be prescribed in office-based settings by qualified clinicians. Extended-release naltrexone requires the person to complete an opioid-free period before it can be started safely. Medication selection should be based on current opioid exposure, medical history, treatment goals, living circumstances, previous treatment experiences, and an evaluation by a qualified prescriber.
Rainbow Hill Recovery identifies medication-assisted treatment as one component of its substance use disorder services. Medication availability and suitability are determined through clinical assessment and may require coordination with outside medical or opioid treatment providers. Behavioral treatment remains important because medication alone may not address trauma, depression, relationships, routines, housing concerns, or identity-related stress affecting recovery. Our goal is to help clients receive coordinated care that supports physical stability while respecting their identity, autonomy, and informed treatment choices.
Therapy helps clients understand the emotions, thoughts, relationships, environments, and routines connected to fentanyl use. Cognitive and behavioral approaches can help identify triggers, challenge automatic beliefs, and create safer responses to pain, stress, cravings, and social pressure. Dialectical Behavior Therapy may strengthen mindfulness, emotional regulation, distress tolerance, communication, and decision-making. Trauma-informed treatment can also help clients address painful experiences without using shame, confrontation, or forced disclosure.
Affirmative therapy respects a client’s sexual orientation, gender identity, relationships, and lived experiences while addressing addiction and mental health concerns. A person may want to discuss family rejection, coming out, gender dysphoria, discrimination, relationship violence, spirituality, chosen family, or safety within their community. Another client may not view identity-related experiences as central to treatment and should not be pressured to explore them. Individualized care allows each person to decide which experiences matter while receiving practical help with cravings, emotional health, relationships, and recovery.
Treatment may include individual therapy, group therapy, addiction education, case management, relapse-prevention planning, psychiatric support, and practical skill development. Clients may need help restoring sleep, rebuilding relationships, managing legitimate pain, creating daily structure, and addressing co-occurring anxiety or depression. Recovery planning should account for the environments where fentanyl was available and the situations most likely to trigger renewed use. Practicing coping strategies during treatment helps clients prepare to use those skills outside the program.
An opioid overdose may cause very slow or stopped breathing, an inability to wake the person, choking or gurgling sounds, extremely small pupils, a limp body, or pale, gray, or bluish skin. An overdose is always a medical emergency, even when the exact substance is unknown. Call 911 immediately, administer naloxone when available, and remain with the person until emergency responders arrive. More than one naloxone dose may be necessary when a potent synthetic opioid is involved.
Naloxone is an FDA-approved medication that can rapidly reverse an opioid overdose when administered in time. It is widely available as a nasal spray and can be used by people without formal medical training. Naloxone temporarily restores breathing by blocking opioid effects, but it does not replace emergency evaluation because overdose symptoms can return after the medication wears off. Partners, relatives, chosen family members, friends, roommates, and others in a client’s support system should know where naloxone is stored and how to use it.
Rainbow Hill Recovery offers Partial Hospitalization, Intensive Outpatient, Outpatient, and Virtual IOP services for adults who are clinically appropriate for outpatient care. PHP provides a high level of daily structure, while IOP combines frequent therapeutic support with increased independence outside program hours. OP may be appropriate for clients who need flexible continuing treatment or are transitioning from a more structured program. Virtual IOP provides remote access to structured care when telehealth is appropriate for the client’s safety, privacy, technology access, and living situation.
Program placement depends on medical stability, withdrawal needs, overdose history, mental health symptoms, opioid-use severity, living conditions, responsibilities, and available support. Outpatient care is not appropriate during an active overdose, serious untreated withdrawal, severe psychiatric instability, or another condition that prevents safe participation. Some people may need medical stabilization, inpatient care, or services from a certified opioid treatment program before entering outpatient treatment. Once stable, clients can focus on therapy, medication coordination, relapse prevention, emotional health, relationships, and continuing recovery.
Fentanyl cravings may be triggered by physical pain, anxiety, depression, conflict, insomnia, money, certain people, familiar locations, drug equipment, or memories of previous use. LGBTQIA+ clients may also encounter triggers connected to rejection, discrimination, misgendering, isolation, family conflict, or returning to an environment where they do not feel safe. Relapse-prevention planning helps clients identify personal warning signs and choose specific actions before cravings become overwhelming. A practical plan may include medication routines, therapy appointments, affirming supportive contacts, naloxone access, safe places, transportation options, and steps to take following a lapse.
Community support can be particularly meaningful for clients who have felt uncomfortable or excluded in traditional treatment environments. People should not have to repeatedly explain their identity, defend their relationships, or wonder whether a recovery setting will respect their name and pronouns. Affirming peer connections may reduce isolation while providing encouragement, accountability, and shared understanding. Partners, chosen family members, supportive relatives, peers, therapists, and community resources may all become important parts of a stable recovery network.
Our aftercare services may include continuing therapy, support groups, regular check-ins, relapse-prevention education, practical resources, and connections to affirming recovery environments. Continuing care gives clients a place to address renewed cravings, pain, emotional distress, relationship changes, and identity-related stress before those challenges grow. A lapse does not erase previous progress, but it should be taken seriously because reduced opioid tolerance can make resumed fentanyl use fatal. Aftercare helps clients adjust their recovery plans and continue moving toward greater stability, connection, and independence.
Rainbow Hill Recovery provides LGBTQIA+-affirming outpatient care for adults who need help addressing fentanyl addiction alongside mental health symptoms, trauma, relationships, identity-related stress, and daily responsibilities. Our multiple levels of care allow treatment intensity to be matched to each client’s medical stability, symptoms, schedule, strengths, living environment, and recovery goals. Clients may receive individual and group therapy, affirmative and trauma-informed services, psychiatric support, medication coordination, case management, relapse-prevention education, and personalized aftercare planning. This coordinated approach addresses immediate opioid-related risks while helping clients pursue recovery without being asked to hide, defend, or minimize who they are.
Someone does not need to wait for an overdose, job loss, damaged relationship, housing crisis, or another severe consequence before seeking help. An assessment can clarify the severity of fentanyl use, identify co-occurring concerns, determine whether medical stabilization is needed, and establish which outpatient program may be appropriate. Rainbow Hill Recovery combines structured addiction treatment with LGBTQIA+-affirming care, behavioral therapy, medication support, practical recovery education, and continuing community connection. Call (310) 341-4887 to speak with our Los Angeles team about fentanyl addiction treatment and the next appropriate step.
Joie Gyondla serves as Rainbow Hill Recovery’s Clinical Support Coordinator, bringing compassion, empathy, and a genuine commitment to supporting every client who walks through our doors. With a background in recovery support, Joie understands the importance of creating a welcoming, organized, and affirming environment where individuals feel seen, valued, and supported throughout their treatment journey.
Working closely with both clients and the clinical team, Joie helps ensure that each person’s experience is as seamless as possible, providing encouragement, guidance, and practical support every step of the way. Her calm presence and dedication to helping others foster a sense of safety and connection that allows clients to focus on what matters most: their recovery.
Joie believes that healing begins with compassion and that even the smallest acts of kindness can make a lasting difference. She is proud to be part of the Rainbow Hill Recovery team, helping create a community where every individual is empowered to build a healthier, more authentic future.
Co-Founder of the LGBTQ+ Association for Addiction and Mental Health Professionals Clinical Outreach Specialist for Rainbow Hill Recovery LGBTQ Sensitivity Training Consultant
Steven Buffin-Stewart is the Case Manager at Rainbow Hill Recovery, with over five years of experience in substance use and mental health treatment. A CADC ll professional in recovery themselves, Steven combines clinical knowledge with lived experience to provide compassionate, coordinated care and foster inclusive, affirming spaces where clients feel supported, empowered, and hopeful in their healing journey.
Steven Buffin-Stewart is the Program and Case Manager at Rainbow Hill Recovery, with over five years of experience in substance use and mental health treatment. A CADC ll professional in recovery themselves, Steven combines clinical knowledge with lived experience to provide compassionate, coordinated care and foster inclusive, affirming spaces where clients feel supported, empowered, and hopeful in their healing journey.
Janae Borrego serves as Rainbow Hill Recovery’s Cross-Cultural Relations Officer and Outpatient Therapist, where she combines her clinical expertise with a deep commitment to fostering an inclusive, culturally responsive environment for every client. Her ability to understand, appreciate, and navigate diverse cultural perspectives has made her an invaluable leader as Rainbow Hill continues to grow and evolve.
In her role, Janae works to strengthen cultural understanding throughout the organization, ensuring that clients, families, and staff feel respected, heard, and represented. She provides ongoing guidance on cultural sensitivity and inclusive practices while helping shape programs that honor the unique identities, backgrounds, and lived experiences of those we serve.
As an Outpatient Therapist, Janae is dedicated to helping clients navigate recovery, mental health, and life’s challenges with compassion, authenticity, and evidence-based care. She believes that meaningful healing begins when individuals feel safe to show up as their authentic selves and receive support that acknowledges the whole person.
Janae is passionate about creating spaces where diversity is celebrated, connection is strengthened, and every individual has the opportunity to heal and thrive. Her leadership continues to advance Rainbow Hill Recovery’s mission of providing affirming, trauma-informed care that meets the evolving needs of the communities we serve.
With over a decade of experience in addiction recovery, Andrew is passionate about helping individuals reclaim their lives and find lasting healing. As Co-founder and Director of Rainbow Hill Recovery, he is dedicated to creating a supportive environment that fosters hope, resilience, and transformation.
Joey Bachrach is the Co-Founder and CEO of Rainbow Hill Recovery, an LGBTQ-affirming mental health and substance use treatment center in Los Angeles. Drawing from both professional leadership and lived recovery experience, Joey is dedicated to creating safe, inclusive spaces where individuals are fully seen, affirmed, and supported on their healing journey.